Ascendis Pharma A (ASND) earnings: date, estimates and history
Price $275.39 · data as of November 13, 2026
Next earnings report
The date appears here once Ascendis Pharma A confirms it, usually two to four weeks before the report.
Track record
Ascendis Pharma A beat the consensus earnings estimate in 3 of its last 5 reports, by −131.3% on average. On report days the stock moved 3.4% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 12, 2026 Sep/2026 | $1.15 | $1.71 | +48.7% | — | — | +6.2% |
| August 13, 2026 Jun/2026 | $0.77 | $0.90 | +17.4% | — | — | −2.7% |
| May 7, 2026 Mar/2026 | $-0.08 | $0.27 | +429.3% | — | — | +1.2% |
| February 11, 2026 Dec/2025 | $-0.06 | $-0.64 | −966.7% | — | — | — |
| November 12, 2025 Sep/2025 | $-0.41 | $-1.17 | −185.4% | — | — | — |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Ascendis Pharma A’s next earnings date?
Ascendis Pharma A has not confirmed its next report date yet. Its last report was on November 12, 2026.
Did Ascendis Pharma A beat earnings last quarter?
Yes, it reported EPS of $1.71 on November 12, 2026 against an estimate of $1.15 (a +48.7% surprise), and the stock moved +6.2% the next trading day.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar